Vapreotide
Pharmaceutical drug
- H01CB04 (WHO)
- D-phenylalanyl-L-cysteinyl-L-tyrosyl-D-tryptophyl-L-lysyl-L-valyl-L-cysteinyl-L-tryptophanamide (2->7)-disulfide
- 103222-11-3
- 23725064
- 46506923
- DB04894
- 64425
- 2PK59M9GFF
- D06281
- DTXSID00883113
- Interactive image
- CC(C)[C@H]1C(=O)N[C@@H](CSSC[C@@H](C(=O)N[C@H](C(=O)N[C@@H](C(=O)N[C@H](C(=O)N1)CCCCN)Cc2c[nH]c3c2cccc3)Cc4ccc(cc4)O)NC(=O)[C@@H](Cc5ccccc5)N)C(=O)N[C@@H](Cc6c[nH]c7c6cccc7)C(=O)N
InChI
- InChI=1S/C57H70N12O9S2/c1-32(2)49-57(78)68-48(55(76)64-44(50(60)71)26-35-28-61-41-16-8-6-14-38(35)41)31-80-79-30-47(67-51(72)40(59)24-33-12-4-3-5-13-33)56(77)65-45(25-34-19-21-37(70)22-20-34)53(74)66-46(27-36-29-62-42-17-9-7-15-39(36)42)54(75)63-43(52(73)69-49)18-10-11-23-58/h3-9,12-17,19-22,28-29,32,40,43-49,61-62,70H,10-11,18,23-27,30-31,58-59H2,1-2H3,(H2,60,71)(H,63,75)(H,64,76)(H,65,77)(H,66,74)(H,67,72)(H,68,78)(H,69,73)/t40-,43+,44+,45+,46-,47+,48+,49+/m1/s1
- Key:SWXOGPJRIDTIRL-DOUNNPEJSA-N
Vapreotide (Sanvar) is a synthetic somatostatin analog. It is used in the treatment of esophageal variceal bleeding[1][2] in patients with cirrhotic liver disease and AIDS-related diarrhea.[3]
It is an 8 residue peptide with sequence H-D-Phe-Cys(1)-Tyr-D-Trp-Lys-Val-Cys(1)-Trp-NH2.
References
- ^ Calès P (April 2008). "Vapreotide acetate for the treatment of esophageal variceal bleeding". Expert Review of Gastroenterology & Hepatology. 2 (2): 185–92. doi:10.1586/17474124.2.2.185. PMID 19072353. S2CID 2681639.
- ^ Fortune BE, Jackson J, Leonard J, Trotter JF (October 2009). "Vapreotide: a somatostatin analog for the treatment of acute variceal bleeding". Expert Opinion on Pharmacotherapy. 10 (14): 2337–42. doi:10.1517/14656560903207019. PMID 19708854. S2CID 24475861.
- ^ DrugBank DB04894
- v
- t
- e
GH/IGF-1 axis signaling modulators
(somatotropin)
- Agonists: Albusomatropin
- Bovine somatotropin
- Efpegsomatropin
- Eftansomatropin alfa
- Growth hormone
- Human placental lactogen
- Lonapegsomatropin
- Placental growth hormone (growth hormone variant)
- Somagrebove
- Somapacitan
- Somatosalm
- Somatotropin
- Somatropin pegol
- Somatrem
- Sometribove
- Somatrogon (MOD-4023; hGH-CTP)
- Somavaratan
- Somavubove
- Somidobove
- Antagonists: G120K-hGH
- Pegvisomant
- Antisense oligonucleotides: Atesidorsen
- Binding proteins: GHBPTooltip Growth hormone-binding protein
(somatostatin)
- Agonists: BIM-23052
- CH-275
- Cortistatin-14
- Depreotide
- Edotreotide
- Ilatreotide
- L-803,087
- L-817,818
- Lanreotide
- NNC 26-9100
- Octreotate
- Octreotide
- Pasireotide
- Pentetreotide
- RC-160
- Seglitide
- Somatostatin (GHIH)
- Somatostatin (1-28)
- SRIF-14
- SRIF-28
- TT-232
- Vapreotide
- Veldoreotide
- Antagonists: BIM-23056
- Cyclosomatostatin
- CYN-154806
- Satoreotide
(somatocrinin)
- Agonists: Peptide: ALRN-5281
- CJC-1295
- Dumorelin
- GHRH
- Modified GRF (1-29)
- Rismorelin
- Sermorelin
- Somatorelin
- Tesamorelin
- Antagonists: MZ-5-156
(ghrelin)
- Agonists: Peptide: Alexamorelin
- Cortistatin-14
- EP-51216
- Examorelin (hexarelin)
- Ghrelin
- GHRP-1
- GHRP-3
- GHRP-4
- GHRP-5
- GHRP-6
- Ipamorelin
- Lenomorelin
- Livoletide
- LY-444711
- Pralmorelin (GHRP-2)
- Relamorelin
- Tabimorelin
- Ulimorelin; Non-peptide: Adenosine
- Anamorelin
- Capromorelin
- CP-464709
- Ibutamoren (MK-677)
- L-692,585
- Macimorelin
- SM-130686; Unsorted: LY-426410
- LY-444711
- Antagonists: A-778193
- Cortistatin-8
- (D-Lys³)-GHRP-6
- JMV2959
- YIL-781
(somatomedin)
- See here instead.
This hormonal preparation article is a stub. You can help Wikipedia by expanding it. |
- v
- t
- e